Business Wire

SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference

1 Mins read

BOSTON & LAUSANNE, Switzerland–(BUSINESS WIRE)–$SOPH #JPM2023–SOPHiA GENETICS SA (NASDAQ: SOPH) today announced that Dr. Jurgi Camblong, Chief Executive Officer and Co-Founder, is scheduled to present at the J.P. Morgan 2023 Healthcare Conference on Tuesday, January 10, 2023, at 8:15 a.m. PST in San Francisco.

Live, listen-only webcasts of this presentation can be accessed by visiting the Investors section of the SOPHiA GENETICS website at A replay of the webcast will be available shortly after the conclusion of the presentation and archived on the company’s website for two weeks following the presentation.


SOPHiA GENETICS (NASDAQ: SOPH) is a cloud-native software company in the healthcare space dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM ™ Platform, a software platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM ™ Platform and related solutions, products, and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, please visit or follow SOPHiA GENETICS on Twitter (@SOPHiAGENETICS).



Media Contact:

Don Granese

Investor Contact:

Katherine Bailon,